MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào)，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù),。

Pertuzumab

CAS No. : 380610-27-5

MCE 國際站：Pertuzumab

產(chǎn)品活性：Pertuzumab 是一種人源化 IgG1 單克隆抗體,，是一種HER2二聚抑制劑?？捎糜谵D(zhuǎn)移性HER2 陽性乳腺癌的研究,。

研究領(lǐng)域：JAK/STAT Signaling  |  Protein Tyrosine Kinase/RTK

作用靶點(diǎn)：EGFR

In Vitro: Trastuzumab and Pertuzumab are highly synergistic inhibitors of BT474 breast cancer cell survival. The combination of trastuzumab and Pertuzumab mediates a loss of up to 60% of cells at doses in which individual drugs do not alter cell survival. The combination of trastuzumab and Pertuzumab reduces the percentage of proliferating (S-phase) cells by more than 2-fold. A combination of trastuzumab and Pertuzumab inhibits cell proliferation and survival to a greater degree than does either agent alone.

In Vivo: In Calu-3 NSCLC xenografts, monotherapy with pertuzumab or trastuzumab is able to significantly inhibit tumor growth, with treatment-to-control ratios (TCR) of 0.23 and 0.27, respectively. The combination of trastuzumab and pertuzumab produces a dramatically enhanced antitumor activity compared with single-agent treatments (TCR 0.05, resulting in tumor regression and, in 3 of 10 animals, complete tumor remission). Treatment of KPL-4 breast cancer xenografts with either trastuzumab or pertuzumab inhibits tumor growth with TCRs of 0.67 and 0.65, respectively. Pertuzumab maintains antitumor activity after progression on trastuzumab.

相關(guān)產(chǎn)品：Antibody Inhibitor Library  |  Osimertinib  |  Trastuzumab  |  Cetuximab  |  Gefitinib  |  Erlotinib  |  Trastuzumab deruxtecan  |  Afatinib  |  Lapatinib  |  Genistein  |  AG490  |  Trastuzumab emtansine  |  Tucatinib  |  Neratinib  |  Amivantamab  |  Disitamab vedotin  |  Dacomitinib  |  AG-1478  |  Panitumumab  |  Patritumab  |  Lazertinib  |  NSC 228155  |  Sapitinib  |  Zanidatamab  |  Almonertinib  |  Mobocertinib  |  Pyrotinib

熱門產(chǎn)品線：重組蛋白  |  藥物篩選  |  天然產(chǎn)物  |  熒光染料  |  PROTAC  |  同位素標(biāo)記物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介紹:
?   MCE (MedChemExpress) 擁有200 多種全球獨(dú)家化合物庫，我們致力于為全球科研客戶提供前沿最全的高品質(zhì)小分子活性化合物,；
?   50,000 多種高選擇性抑制劑,、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng)域；
?   產(chǎn)品種類涵蓋各種重組蛋白,，多肽,，常用試劑盒 ，更有 PROTAC,、ADC 等特色產(chǎn)品,，廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項(xiàng)目,；
?   提供虛擬篩選,，離子通道篩選，代謝組學(xué)分析檢測(cè)分析,，藥物篩選等專業(yè)技術(shù)服務(wù),；
?   設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系,；
?   提供 LC/MS,、NMR、HPLC,、手性分析,、元素分析等各項(xiàng)質(zhì)檢報(bào)告，確保產(chǎn)品的高純度,、高品質(zhì),；
?   產(chǎn)品的生物活性多經(jīng)各國客戶實(shí)驗(yàn)驗(yàn)證；
?   Nature, Cell, Science 等多種頂級(jí)期刊及制藥專利收錄了MCE客戶的科研成果,；
?   專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,，為您提供全球最新的活性化合物；
?   與世界各大制藥公司及知名科研機(jī)構(gòu)建立了長(zhǎng)期的合作,。